15.80
Schlusskurs vom Vortag:
$15.65
Offen:
$15.84
24-Stunden-Volumen:
723.63K
Relative Volume:
1.08
Marktkapitalisierung:
$914.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-14.31%
1M Leistung:
-22.16%
6M Leistung:
-30.04%
1J Leistung:
+0.00%
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
888-987-8337
Adresse
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Vergleichen Sie OMDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OMDA
Omada Health Inc
|
15.79 | 906.26M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.28 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.62 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.25 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.34 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
| 2025-07-01 | Eingeleitet | Barclays | Overweight |
| 2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
| 2025-07-01 | Eingeleitet | Goldman | Buy |
| 2025-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Omada Health (NASDAQ:OMDA) Trading Down 5.1%What's Next? - MarketBeat
Shareholders Should Be Pleased With Omada Health, Inc.'s (NASDAQ:OMDA) Price - 富途牛牛
Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 - openPR.com
Omada Health (NASDAQ:OMDA) Shares Gap DownWhat's Next? - MarketBeat
Omada Health: Business Is Scaling Very Healthily (NASDAQ:OMDA) - Seeking Alpha
Franklin Resources Inc. Makes New Investment in Omada Health, Inc. $OMDA - MarketBeat
Digital Health Coaching Market Size Worth $28.40 Billion by 2032, Drive by AI-Driven Personalization and Rising Demand for Preventive Care – SNS Insider - GlobeNewswire Inc.
Is OMDA Stock Set for a Rebound? - StocksToTrade
Certain Stock Options of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - MarketScreener
Certain Warrants of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Common Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Series A Preferred Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
HBK Investments L P Invests $1.37 Million in Omada Health, Inc. $OMDA - MarketBeat
1,090,056 Shares in Omada Health, Inc. $OMDA Acquired by Loomis Sayles & Co. L P - MarketBeat
Omada Health, Inc. (NASDAQ:OMDA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Omada Health, Inc.'s (NASDAQ:OMDA) Lock-Up Period To End on December 3rd - MarketBeat
Oversold Conditions For Omada Health (OMDA) - Nasdaq
Omada Health to Participate in Evercore Healthcare Conference - The Manila Times
United States 7MM Digital Therapeutics for Diabetes Market: FDA - openPR.com
Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach - TipRanks
Omada Health's Integrated Approach Powers Growth in Digital Therapeutics () - aktiencheck.de
OMDA: BMO Capital Initiates Coverage with "Outperform" Rating | - GuruFocus
Thought bubble: Omada's about-face - Axios
Omada Health initiated with an Outperform at BMO Capital - TipRanks
Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities - TipRanks
EBIT per share of Omada Health, Inc. – MUN:U76 - TradingView
Inside Omada's pivot toward GLP-1 prescriptions - Axios
Cash from financing activities of Omada Health, Inc. – FWB:U76 - TradingView
Omada Health Reports Strong Q3 2025 Growth - MSN
How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News
Free cash flow per share of Omada Health, Inc. – MUN:U76 - TradingView
Omada Health, Inc. Earnings and Revenue – MUN:U76 - TradingView
Omada Health (OMDA): Assessing Valuation After Recent Stock Declines - Yahoo Finance
Latin America Digital Therapeutics Market Poised - openPR.com
Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push - Stocktwits
Omada Health, Inc. Balance Sheet – FWB:U76 - TradingView
Omada Health announces GLP-1 prescribing capability - MSN
Omada Health raises FY25 revenue view to $251.5M-$254.5M from $235M-$241M - MSN
Omada Health reports Q3 EPS (6c), consensus (7c) - MSN
Omada Health Reports Strong Growth and Innovation - MSN
Omada Health price target raised to $32 from $30 at Morgan Stanley - MSN
Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price - MarketBeat
Omada Health price target raised to $28 from $27 at Evercore ISI - MSN
Evercore ISI Group Maintains Omada Health (OMDA) Outperform Recommendation - MSN
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs - Business Insider
Omada Health Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Omada Health to prescribe GLP-1s - TechTarget
Evercore ISI Group Raises Price Target for OMDA to $28.00 | OMDA Stock News - GuruFocus
Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating - TipRanks
Omada Health to present RWE on behavior change program at ObesityWeek - MSN
Omada Health, Inc.: Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):